- Home
- NHPBP vs IRTC Comparison
NHPBP vs IRTC Comparison
Compare NHPBP & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NHPBP
- IRTC
- Stock Information
- Founded
- NHPBP N/A
- IRTC 2006
- Country
- NHPBP United States
- IRTC United States
- Employees
- NHPBP N/A
- IRTC N/A
- Industry
- NHPBP Real Estate Investment Trusts
- IRTC Medical/Dental Instruments
- Sector
- NHPBP Real Estate
- IRTC Health Care
- Exchange
- NHPBP Nasdaq
- IRTC Nasdaq
- Market Cap
- NHPBP N/A
- IRTC 3.5B
- IPO Year
- NHPBP N/A
- IRTC 2016
- Fundamental
- Price
- NHPBP $13.64
- IRTC $110.85
- Analyst Decision
- NHPBP
- IRTC Strong Buy
- Analyst Count
- NHPBP 0
- IRTC 10
- Target Price
- NHPBP N/A
- IRTC $107.80
- AVG Volume (30 Days)
- NHPBP N/A
- IRTC 450.5K
- Earning Date
- NHPBP N/A
- IRTC 02-20-2025
- Dividend Yield
- NHPBP N/A
- IRTC N/A
- EPS Growth
- NHPBP N/A
- IRTC N/A
- EPS
- NHPBP N/A
- IRTC N/A
- Revenue
- NHPBP N/A
- IRTC $560,025,000.00
- Revenue This Year
- NHPBP N/A
- IRTC $21.10
- Revenue Next Year
- NHPBP N/A
- IRTC $16.18
- P/E Ratio
- NHPBP N/A
- IRTC N/A
- Revenue Growth
- NHPBP N/A
- IRTC 18.45
- 52 Week Low
- NHPBP N/A
- IRTC $55.92
- 52 Week High
- NHPBP N/A
- IRTC $124.12
- Technical
- Relative Strength Index (RSI)
- NHPBP N/A
- IRTC 68.03
- Support Level
- NHPBP N/A
- IRTC $104.97
- Resistance Level
- NHPBP N/A
- IRTC $112.78
- Average True Range (ATR)
- NHPBP 0.00
- IRTC 4.48
- MACD
- NHPBP 0.00
- IRTC -0.34
- Stochastic Oscillator
- NHPBP 0.00
- IRTC 82.05
About NHPBP National Healthcare Properties Inc. 7.125% Series B Cumulative Redeemable Perpetual Preferred Stock
National Healthcare Properties Inc is a publicly registered real estate investment trust focused on acquiring a diversified portfolio of healthcare real estate, with an emphasis on seniors housing and outpatient medical facilities, located in the United States.
About IRTC iRhythm Technologies Inc.
iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities. The company's portfolio includes ambulatory cardiac monitoring services on a platform, called the Zio service, which combines an easy-to-wear and unobtrusive biosensor that can be worn for several days with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company derived its revenue from the United States.